Interim Report January – September 2021
STOCKHOLM, SE / ACCESSWIRE / November 23, 2021 / Promore Pharma (STO:PROMO) (FRA:8T0)July to SeptemberNet sales amounted to MSEK 0...
Year: 2021
NeonMind Announces Successful Completion of Pre-IND Consultation with FDA on Clinical Path for Obesity Drug Candidate NEO-001
FDA feedback provides clear clinical path for NEO-001, the first obesity drug therapy focused on neuropharmacological and behavioral changes for...
Psyched Wellness Appoints Chief Commercial Officer to Lead Sales and Marketing of AME-1 and Launch CPG Products
Toronto, Ontario--(Newsfile Corp. - November 23, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or...
LivaNova to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
LONDON--(BUSINESS WIRE)--#cardiovascular--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced that Damien McDonald, Chief Executive Officer, will...
Masimo to Present in Piper Sandler 33rd Annual Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Piper Sandler 33rd Annual...
Former CMS Information Chief Officer Tony Trenkle Joins Board of Onyx Technology
Trenkle brings extensive federal experience to Onyx’s industry leading health data interoperability platform ELKRIDGE, Md.--(BUSINESS WIRE)--#healthcare--Onyx Technology, LLC, a NewWave...
Hologic to Host Innovative Product Experiences and Medical Education Sessions On-site and Virtually at RSNA 2021
Leader in women's health to showcase clinically proven solutions across the continuum of breast and skeletal health at annual meeting...
Endologix Announces Completion of Enrollment in the TORUS 2 Study for PAD in SFA
The TORUS 2 study is a prospective, single-arm trial of 188 patients to evaluate safety and effectiveness of the TORUS...
Defence Therapeutics Cancer Vaccine AccuVac-D001 Manufacturing Targets Melanoma and Breast Cancer
Vancouver, British Columbia--(Newsfile Corp. - November 23, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"...
Biophytis Obtains a New 10M€ Loan Structure With Kreos Capital
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / November 22, 2021 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris: ALBPS) (the "Company"...
Empower Clinics Releases Q3 2021 Results with 372% Year-Over-Year Revenue Growth
The Company Reports nine-month year-over-year revenue growth of 1,349%VANCOUVER, BC / ACCESSWIRE November 22, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF)...
Pharnext Appoints Dr. Burkhard Blank as New Chief Medical Officer and Head of Research & Development
Dr. Burkhard Blank brings more than 25 years of industry experience and will support the ongoing PREMIER pivotal Phase III...
Meet the BIOMEDevice Silicon Valley 2021 Keynote Lineup: Two Expert-led Panels Set to Explore the Convergence of Advanced Tech and Healthcare
Tune in to two days of forward-looking and inspirational keynote panels presented by eight of the industry’s most prominent leaders...
XVIVO Expands its Management Team by Appointing Jaya Tiwari to Vice President Clinical and Regulatory Affairs for the US
GOTHENBURG, SE / ACCESSWIRE / November 22, 2021 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)To further optimize the commercialization process...
Limitless Venture Group, Inc. Posts Record Revenue for The Third Quarter 2021, The Sixth Consecutive Record Revenue Quarter and has Already More than Doubled 2020 Annual Revenues, Equaling $.0732/Share in Revenues
TULSA, OK / ACCESSWIRE / November 22, 2021 / Limitless Venture Group, Inc. (OTC PINK:LVGI) ("LVGI" or the "Company"), a...
Halberd Successfully Eradicates TNF-a, a Major Contributing Factor to Alzheimer’s Disease
JACKSON CENTER, PA / ACCESSWIRE / November 22, 2021 / Halberd Corporation (OTC PINK:HALB) successfully eradicated 85% of Tumor Necrosis...
StageZero Life Sciences ARISTOTLE(R) Multi-Cancer Blood Test Now Available in Greater Toronto Area
First-ever mRNA multi-cancer panel simultaneously screens for multiple cancers from a single sample of bloodTORONTO, ON and RICHMOND, VA /...
Clearmind Medicine to Pursue Dual Listing on Nasdaq
Toronto, Ontario, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0, OTC Pink: CMNDF), (“Clearmind” or...
Former CPO of Convoy and Marchex Joins H1 as Chief Operating Officer
Ziad Ismail Joins H1 During Period of High Growth for Leading Global Healthcare Network Ziad Ismail, COO of H1 Former...
Zealand Pharma announces successful outcome of Phase 1b clinical trial with GLP1-GLP2 dual receptor agonist, dapiglutide
Company announcement – No. 70 / 2021 Zealand Pharma announces successful outcome of Phase 1b clinical trial with GLP1-GLP2 dual receptor agonist,...